Abbott, Alere Stalled Takeover Fight May Be Heard in January

Updated on
  • Court’s former chief judge will serve as mediator if needed
  • Abbott proposed schedule for antitrust regulatory filings

Alere Inc.’s bid to force Abbott Laboratories to complete its stalled $5.8 billion takeover of the medical testing company could linger into January.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.